A leading pharmaceutical company importing life saving drug IVIGLOB-EX, which is used by AIDS and cancer patients has approached the Bombay High Court against the ban on their drugs by the Tata Memorial Centre.
VHB Life Sciences Limited filed a petition in the high court challenging the ban by Tata Memorial Centre on the drug, which is used to increase immunity in terminally ill AIDS and cancer patients.
A vacation bench of justice JH Bhatia and justice AP Bhangale has asked the Tata Memorial Centre to file its reply and kept the matter for hearing on November 22.
However, the court refused to interfere saying that it was a matter of life and death.
The drug is imported by VHB Life Sciences and is distributed by Shree Vinayak, a Sewri-based trading company.
Tata Memorial Centre had banned the drug after Food and Drug Administration (FDA) conducted raids in March on Shree Vinayak.
During the raid, the FDA allegedly seized several bottles of spurious drugs from the premises. The injection bottles that were seized were similar to a drug called EL-Gam, another drug which has similar ingredients as that of IVIGLOB-EX, but is cheaper that the imported drug.
FDA had seized 24 bottles from the premises of Shree Vinayak. It was also found that Shree Vinayak had distributed over 300 bottles valued at Rs 65 lakh. The FDA found during the raids that the medical stores near reported hospitals, including the Tata Memorial Centre, sold IVIGLOB-EX, which were not identical to the imported ones.
Advocate for Tata Memorial Centre argued that the investigation was on and that the company was still under scanner by various departments.